🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Endurance Trial is a phase IV open label clinical study to assess the n...
Status
Completed
Location
Multiple Locations
Start Date
2014-11
Trial ID
NCT02297204
Treatments Being Tested
The purpose of this study is to determine whether fluorescence angiography ...
Status
Terminated
Location
University Hospital of Grenoble
Start Date
2012-08
Trial ID
NCT01681797
Treatments Being Tested
Age-Related Macular Degeneration (ARMD) is the most common cause of blindne...
Status
Completed
Location
CHU Brugmann
Start Date
2013-08-01
Trial ID
NCT02762188
Treatments Being Tested
This study mainly observed the ischemic index and vascular leakage index ch...
Status
Unknown
Location
Renmin Hospital of Wuhan University
Start Date
2023-10-09
Trial ID
NCT04140448
Treatments Being Tested
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
Idiopathic edema (IE) is an ill-defined syndrome of uncertain etiology that...
Status
Completed
Location
Winthrop-University Hospital
Start Date
2011-09
Trial ID
NCT01681927
In patients with macular edema secondary to CRVO, Aflibercept demonstrated ...
Status
Completed
Location
Centre Hospitalier Intercommunal Créteil
Start Date
2017-01-26
Trial ID
NCT02880644
The CEDIP LCI study is intended to show the difference in intestinal permea...
Status
Terminated
Location
University Medical Center of the Johannes Gutenber Univeristy
Start Date
2017-08-01
Trial ID
NCT03658551
Treatments Being Tested
1. To identify the underlying causes of macular haemorrhages in patients wi...
Status
Completed
Location
Singapore National Eye Centre
Start Date
2004-06
Trial ID
NCT00345228
Diabetic retinopathy(DR) is one of the most common and serious microvascula...
Status
Completed
Location
Qianli Meng
Start Date
2017-06-13
Trial ID
NCT03528720